NPHC

$0.00+0.00%visit website

NPHC

Market Cap

$715,972.721

Live price × SEC shares (Aug 19, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.22

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

4.5

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	70	29	27	34	161
Cost of revenue	34	66	29	25	155
Gross profit	65	(12)	19	33	104
Selling, general & administrative	421
Total operating expenses	421	454	398	468	1,741
Operating income	(356)	(466)	(379)	(435)	(1,637)
Interest expense	5.8	6.0	6.0	6.2	24.0
Pretax income	(524)	(489)	(460)	(3,949)	(5,420)
Net income	(524)	(489)	(460)	(3,949)	(5,420)
EPS (basic) ($)	0.00		0.00	0.00	0.00
EPS (diluted) ($)	0.00		0.00	0.00	0.00
Weighted avg. shares (basic)	7,816,233		8,011,436	8,066,882
Weighted avg. shares (diluted)	7,816,233		8,011,436	8,066,882

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 19, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.